Two Sigma Investments’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Two Sigma Investments’s Portfolio RSLS Stock Details RSLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-568	Closed	-$4K	–	3778
2018 Q3	$4K	Buy	+568	New	+$48.9K	﹤0.01%	3120

Other funds holding RSLS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Two Sigma Investments's RSLS Position: Q4 2018 in Review

Two Sigma Investments sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 568 shares — an estimated $4K sold.

Two Sigma Investments first reported a position in RSLS in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

Two Sigma Investments reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Two Sigma Investments sold 568 ReShape Lifesciences Inc. Common Stock shares in Q4 2018, an estimated $4K.
Two Sigma Investments first reported a position in ReShape Lifesciences Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Two Sigma Investments's ReShape Lifesciences Inc. Common Stock position peaked at $4K in Q3 2018.
2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.